Gufic Biosciences Limited has informed the Exchange about further investment in Saraswat Co-operative Bank Limited
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences Limited has approved investment of Rs. 5.75 crore in Saraswat Co-operative Bank Limited through subscription to 57,50,800 equity shares at face value of Rs. 10 each. The company's shareholding increases from 7,500 shares to 57,58,300 shares post-acquisition. The investment aims to strengthen the existing banking relationship with Saraswat Bank, which already provides credit facilities to Gufic Biosciences. The transaction is for treasury management purposes and may generate returns through dividend income and investment appreciation. Consideration is cash, to be completed within four months, and is not a related party transaction.
This is a minor strategic investment rather than a core business expansion. The Rs. 5.75 crore outlay is unlikely to materially impact Gufic Biosciences financials but signals intent to deepen banking partnerships. Minimal direct impact on stock price expected.